REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

WuXi Biologics Cayman Inc. (药明生物技术有限公司) (Hong Kong SAR, China)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences
Full name: WuXi Biologics Cayman Inc. Profile Updated: October 22, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

WuXi Biologics Cayman Inc. engages in the provision of biologics services that offers comprehensive, integrated and highly customizable services to pharmaceutical and biotechnology companies. The company was founded in 2014 and is based in Shanghai, China.

Headquarters
No. 88 Meiliang West Road, Mashan
Wuxi; Jiangsu;

Contact Details: Purchase the WuXi Biologics Cayman Inc. (药明生物技术有限公司) report to view the information.

Website: http://www.wuxibiologics.com.cn

Basic Information
Total Employees:
Purchase the WuXi Biologics Cayman Inc. (药明生物技术有限公司) report to view the information.
Outstanding Shares:
Purchase the WuXi Biologics Cayman Inc. (药明生物技术有限公司) report to view the information.
Registered Capital:
Purchase the WuXi Biologics Cayman Inc. (药明生物技术有限公司) report to view the information.
Financial Auditors:
Purchase the WuXi Biologics Cayman Inc. (药明生物技术有限公司) report to view the information.
Incorporation Date:
December 09, 2025
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
12.32%
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Wuxi Biologics Alliance
100%
Wuxi Biologics Healthcare Venture (Cayman) Inc. (United Kingdom)
100%
Wuxi Biologics Healthcare Venture Hong Kong Holding Limited
100%
Company Performance
Financial values in the chart are available after WuXi Biologics Cayman Inc. (药明生物技术有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HKD. Absolute financial data is included in the purchased report.
Net sales revenue
14.42%▲
Total operating revenue
13.88%▲
Operating profit (EBIT)
28.91%▲
EBITDA
28.56%▲
Net Profit (Loss) for the Period
52.63%▲
Total assets
7.81%▲
Total equity
10%▲
Operating Profit Margin (ROS)
3.17%▲
Net Profit Margin
6.94%▲
Return on Equity (ROE)
1.63%▲
Debt to Equity Ratio
0.17%▲
Quick Ratio
0.07%▲
Cash Ratio
-0.4%▼

Similar companies

Genscript Biotech Corporation (Hong Kong) (金斯瑞生物科技股份有限公司 (香港))
 
Austar Lifesciences Limited
BBI Life Sciences Corporation (Hong Kong) (BBI生命科学有限公司 (香港))
 
Keymed Biosciences Inc. (Hong Kong) (康诺亚生物医药科技有限公司 (香港))
Crushmetric Group Ltd.
 
Ascletis Pharma Inc.

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo